• Education

    Albert Einstein College of Medicine, MD, 1992

  • Residencies

    UCSF Benioff Children's Hospital, Oakland, Pediatrics, 1995

  • Fellowships

    UCSF Benioff Children's Hospital, Oakland, Pediatric Hematology-Oncology, 1998

  • Academic Title

    Professor

Clinics I work with

(1)

oncology-clinic-320x320-2x 3

Oncology Clinic

Oncology Clinic

San Francisco / Oakland / Walnut Creek

Where I see patients (2)

Expand Map

    Decorative Caduceus

    Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philad...

    Will compare the DFS of standard risk Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL) patients treated continuous imatinib mesylate with high risk Children's Oncology Group (COG)-ALL chemotherapy backbone or more ...

    Recruiting

    More about this study
    Decorative Caduceus

    Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With ...

    A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...

    Recruiting

    More about this study
    Decorative Caduceus

    Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders W...

    Will be determined by Response Evaluation Criteria in Solid Tumors. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score int...

    Recruiting

    More about this study
    Decorative Caduceus

    Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Re...

    Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score interval method.

    Recruiting

    More about this study
    Decorative Caduceus

    A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Dia...

    Will be assessed in SR-High patients and SR-Avg B-ALL patients who are negative for MRD by flow cytometry but have detectable or indeterminate MRD as measured by high throughput sequencing (HTS) at end of induction (EOI), and pati...

    Recruiting

    More about this study
    Decorative Caduceus

    Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders ...

    A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...

    Recruiting

    More about this study
    Decorative Caduceus

    Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors,...

    Defined as a patient who achieves a best response of partial response or complete response on the study. Confidence intervals will be constructed using the Wilson score interval method.

    Recruiting

    More about this study
    See all clinical trials

    Tender wagging care

    Our therapy dogs spread joy and smiles at the bedside and throughout the hospital.

    Visit Child Life services

    Share